MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 195 filers reported holding MEDICINES CO in Q3 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $830,000 | +58.7% | 16,594 | +15.8% | 0.31% | +62.3% |
Q2 2019 | $523,000 | +27.9% | 14,329 | -2.1% | 0.19% | +21.7% |
Q1 2019 | $409,000 | +45.0% | 14,629 | -0.8% | 0.16% | +28.7% |
Q4 2018 | $282,000 | -36.1% | 14,753 | 0.0% | 0.12% | -22.3% |
Q3 2018 | $441,000 | -18.5% | 14,753 | 0.0% | 0.16% | -16.0% |
Q2 2018 | $541,000 | +11.3% | 14,753 | 0.0% | 0.19% | +13.3% |
Q1 2018 | $486,000 | +20.6% | 14,753 | 0.0% | 0.16% | +19.6% |
Q4 2017 | $403,000 | +76.8% | 14,753 | +139.6% | 0.14% | +66.3% |
Q3 2017 | $228,000 | -2.6% | 6,157 | 0.0% | 0.08% | 0.0% |
Q2 2017 | $234,000 | -24.8% | 6,157 | -3.1% | 0.08% | -22.4% |
Q1 2017 | $311,000 | -27.8% | 6,353 | -50.0% | 0.11% | -31.8% |
Q4 2016 | $431,000 | +93.3% | 12,708 | +91.8% | 0.16% | +70.7% |
Q2 2016 | $223,000 | -14.6% | 6,626 | -27.4% | 0.09% | -20.0% |
Q2 2015 | $261,000 | +2.0% | 9,125 | 0.0% | 0.12% | +3.6% |
Q1 2015 | $256,000 | +1.6% | 9,125 | 0.0% | 0.11% | -3.5% |
Q4 2014 | $252,000 | – | 9,125 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |